Gaithersburg, MD, United States of America

Hong Lu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Inventor Hong Lu

Introduction

Hong Lu is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 3 patents to his name, Lu's work focuses on innovative methods for treating tumors.

Latest Patents

Among his latest patents, Lu has developed Anti-B7-H1 antibodies for treating tumors. These patents detail methods of treating B7-H1-expressing tumors by administering an effective amount of MEDI4736 or an antigen-binding fragment thereof. This innovative approach has the potential to improve treatment outcomes for patients with specific tumor types.

Career Highlights

Lu is currently associated with MedImmune Limited, a leading biotechnology company. His work at MedImmune has allowed him to explore cutting-edge research and contribute to advancements in cancer therapy. His expertise in antibody development has positioned him as a key figure in the field.

Collaborations

Throughout his career, Lu has collaborated with notable colleagues, including Rajesh Narwal and David Fairman. These collaborations have fostered a productive research environment, leading to significant advancements in their shared field of study.

Conclusion

In summary, Hong Lu is an influential inventor whose work in developing Anti-B7-H1 antibodies has the potential to transform cancer treatment. His contributions to MedImmune Limited and collaborations with esteemed colleagues highlight his commitment to innovation in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…